These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7930761)

  • 21. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
    Hamase A; Kawanaka M; Kitani H; Fukuchi M
    Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18.
    Bonfrer JM; Groeneveld EM; Korse CM; van Dalen A; Oomen LC; Ivanyi D
    Tumour Biol; 1994; 15(4):210-22. PubMed ID: 7524130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokeratins and proliferation in breast cancer patients.
    Correale M; Reshkin S; Tedone T; Abbate I; Mangia A; Schittulli F; Paradiso A
    Int J Oncol; 1996 Nov; 9(5):1007-12. PubMed ID: 21541608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of TPS in breast cancer.
    Karaloglu D; Yasasever V; Ertürk N; Dalay N
    Eur J Gynaecol Oncol; 1995; 16(5):363-7. PubMed ID: 8549601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CA-15.3, TPA and MCA as markers for breast cancer.
    Barak M; Steiner M; Finkel B; Abrahamson J; Antal S; Gruener N
    Eur J Cancer; 1990; 26(5):577-80. PubMed ID: 2144745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokeratins as serum markers in egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS.
    Mady EA
    Int J Biol Markers; 2001; 16(2):130-5. PubMed ID: 11471896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical parameters for prognostic evaluation in patients with breast cancer.
    Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Sampognaro E; Meo S
    Anticancer Res; 1994; 14(2B):693-8. PubMed ID: 8010728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma.
    Suzuki S; Furukawa H; Tsuchiya A
    Thyroid; 1999 Sep; 9(9):921-5. PubMed ID: 10524571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
    Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
    Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor markers TPA, TPS, TPACYK and CYFRA 21-1 react differently with the keratins 8, 18 and 19.
    Bodenmüller H; Donié F; Kaufmann M; Banauch D
    Int J Biol Markers; 1994; 9(2):70-4. PubMed ID: 7523544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of neoadjuvant chemotherapy on serum tumor markers CA 15-3, MCA, CEA, TPS and TPA in breast cancer patients with operable disease.
    Bottini A; Berruti A; Tampellini M; Morrica B; Brunelli A; Gnocchi E; Brizzi MP; Aguggini S; Fara E; Alquati P; Dogliotti L
    Tumour Biol; 1997; 18(5):301-10. PubMed ID: 9276030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum TPS versus TPA in Egyptian bladder cancer patients.
    Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
    Int J Biol Markers; 1993; 8(4):221-6. PubMed ID: 7511149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer.
    Sjöström J; Alfthan H; Joensuu H; Stenman UH; Lundin J; Blomqvist C
    Scand J Clin Lab Invest; 2001; 61(6):431-41. PubMed ID: 11681532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of CEA, TPA, CA 15-3, CA 549 and TPS in the monitoring of metastatic breast cancer.
    Nicolini A; Ferdeghini M; Colizzi C
    J Nucl Biol Med (1991); 1993 Sep; 37(3):126-33. PubMed ID: 8218459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
    Tarle M; Kovacić K; Kastelan M
    Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
    Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
    Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancer.
    Locker GJ; Mader RM; Braun J; Sieder AE; Marosi C; Rainer H; Jakesz R; Steger GG
    Oncology; 1995; 52(2):140-4. PubMed ID: 7854774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.